Beta Bionics (IPO)

Funding Details
Awarder
Inbox
Date Award
January 06, 2025
Vertical
Medical Devices
Funding URL
View Funding Page

Company Info
Traction
Beta Bionics reported revenue of $44.7 million and a net loss of $36.6 million for the nine months ending in September 2024, with an installed customer base of 11,214 people.
Revenue Amount
$44,700,000
Company Description
Beta Bionics is a developer of an automated insulin delivery system, specifically the iLet Bionic Pancreas, which automates insulin dosing without any mealtime carb counting.
Market
Diabetes
Location
Irvine, California, United States

Links
Back to Home Back to Medical Devices Deals View Funding Announcement